Gilead Sciences, Inc.
Time frame: 1 January 2023 - 31 December 2023Article ‘Count’ and ‘Share’ for Gilead Sciences, Inc. based on listed parameters only.
The articles listed below published by authors from Gilead Sciences, Inc., organized by journal and article, represent the research output in Count and Share according to the parameters selected above.
Journal | Count | Share |
---|---|---|
Annals of the Rheumatic Diseases |
1 | 0.11 |
Blood |
2 | 0.51 |
Clinical Infectious Diseases |
4 | 0.63 |
Gut |
2 | 0.35 |
Hepatology |
2 | 0.62 |
JAMA: The Journal of the American Medical Association |
1 | 0.09 |
Journal of Clinical Oncology |
2 | 0.42 |
Journal of Hepatology |
2 | 0.90 |
Journal of Infectious Diseases |
3 | 1.28 |
Nature |
2 | 0.23 |
Nature Communications |
3 | 0.13 |
The Lancet |
2 | 0.40 |
The New England Journal of Medicine |
2 | 0.47 |
Numerical information only is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.